Physical exercise as a treatment for adult and juvenile myositis

Journal of Internal Medicine

Volumn 280, Issue 1, 2016, Pages 75-96

  Alexanderson, H ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

aerobic exercise; disease activity; impairment; inflammation; inflammatory myopathies; resistance training

Indexed keywords

AEROBIC CAPACITY; DISEASE ACTIVITY; ENVIRONMENTAL FACTOR; EXERCISE; HUMAN; MUSCLE EXERCISE; MUSCLE FATIGUE; MUSCLE METABOLISM; MUSCLE STRENGTH; MYALGIA; MYOSITIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SKELETAL MUSCLE; SUPPLEMENTATION;

EID: 84975119929     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12481     Document Type: Review

References (56)

1. Gazeley DJ, Cronin ME. Diagnosis and treatment of the idiopathic inflammatory myopathies. Ther Adv Musculoskelet Dis 2011; 3: 315–24.
2. Rider GL, Katz JD, Jones OY. Developments of the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2013; 39: 28.
3. Lundberg IE, Vencovsky J, Alexanderson H. Therapy of myositis: biological and physical. Curr Opin Rheumatol 2014; 26: 704–11.
4. World Health Organization. The International Classifications of Functioning Disability and Health. Geneva: World Health Organization, 2001.
5. Hurkmans E, van der Giesen FJ, Vliet Vlieland TPM et al. Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis (Review). Cochrane Database Syst Rev 2009 Oct 7;(4):CD006853. doi: 10.1002/14651858.CD006853.pub2.
6. Voet NBM, van der Kooi EL, Riphagen II et al. Strength training and aerobic exercise training for muscle disease (Review). Cochrane Database Syst Rev 2013 Jul 9;(7):CD003907. doi: 10.1002/14651858.CD003907.pub4.
7. Alemo Munters L, Dastmalchi M, Andgren V et al. Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension follow-up. Arthritis Care Res (Hoboken) 2013; 65: 1959–68.
8. Alemo Munters L, Dastmalchi M, Katz A et al. Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis. Arthritis Res Ther 2013; 15: R83.
9. Alexanderson H, Alemo Munters L, Dastmalchi M et al. Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis – a randomized controlled single-blinded study with a 2-year followup. J Rheumatol 2014; 41: 1124–32.
10. Habers GE, Takken T. Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy – a systemic review. Rheumatology (Oxford) 2011; 50: 2113–24.
11. Hicks JE, Miller F, Plotz P et al. Isomtric exercise increases strength and does not produce sustained creatinine phosphokinase increases in a patients with polymyositis. J Rheumatol 1993; 20: 1399–401.
12. Escalante A, Miller L, Beardmore TD. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. J Rheumatol 1993; 20: 1340–4.
13. Wiesinger GF, Quittan M, Aringer M et al. Improvements of physical fitness and muscle strength in polymyositis/dermatomyositis patients. Br J Rheumatol 1998; 37: 196–200.
14. Wiesinger GF, Quittan M, Graninger M et al. Benfit of 6-months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol 1998; 37: 1338–42.
15. Alexanderson H, Stenström CH, Lundberg I. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford) 1999; 38: 608–11.
16. Alexanderson H, Stenström CH, Jenner G et al. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol 2000; 29: 295–301.
17. Heikkilä S, Viitanen JV, Kautiainen H et al. Rehabilitation in myositis. Physiotherapy 2001; 87: 301–9.
18. Varju C, Pethö E, Kutas R. The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis. Clin Rehabil 2003; 17: 83–7.
19. Harris-Love MO. Safety and efficacy of submaximal eccentric strength training for a subject with polymyositis. Arthritis Rheum 2005; 53: 471–4.
20. Alexanderson H, Dastmalchi M, Esbjörnsson-Liljedahl M et al. Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum 2007; 57: 768–77.
21. Dastmalchi M, Alexanderson H, Loell I et al. Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis. Arthritis Rheum 2007; 57: 1303–10.
22. Chung YL, Alexanderson H, Pipitone N et al. Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: six-month, double-blind, randomized placebo-controlled trial. Arthritis Rheum 2007; 57: 694–702.
23. Nader GA, Dastmalchi M, Alexanderson H et al. A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis. Mol Med 2010; 16: 455–64.
24. Hejazi SM, Engkasan JP, Qomi MSM. Intensive exercise and a patient in acute phase of polymyositis. J Back Musculoskelet Rehabil 2012; 25: 231–4.
25. Mattar MA, Gualano B, Perandini LA et al. Safety and possible effects of low-intensity resistance training associated with partial blood flow restriction in polymyositis and dermatomyositis. Arthritis Res Ther 2014; 16: 473.
26. Mattar MA, Gualano B, Hamilton R et al. Exercise as an adjuvant treatment in persistent active polymyositis. J Clin Rheumatol 2014; 20: 11–5.
27. Regardt M, Schult ML, Axelsson Y et al. Hand exercise intervention in patients with polymyositis and dermatomyositis: a pilot study. Musculoskeletal Care 2014; 12: 160–72.
28. Dalise S, Bertolucci F, Simonella C et al. Intensive aerobic training improves motor performances and oxidative metabolism efficiency in chronic polymyositis: a case report. Neuromuscul Disord 2012; 22: 221–5.
29. Karper WB, Hopewell R, Hodge M. Exercise program effects on one woman with dermatomyositis. Rehabil Nurs 2001; 26: 129–31.
30. Spector SY, Lemmer JT, Koffman BM et al. Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve 1997; 20: 1242–8.
31. Arnardottis S, Alexanderson H, Lundberg IE et al. Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J Rehabil Med 2003; 35: 31–5.
32. Bertolucci F, Neri R, Dalise S et al. Abnormal lactate levels in patients with polymyositis and dermatomyositis: the benefits of a specific rehabilitative program. Eur J Phys Rehabil Med 2013; 49: 9.
33. Johnson LG, Edwards DJ, Walters S et al. The effectiveness of an individualized home-based functional exercise program for patients with sporadic inclusion body myositis. J Clin Neuromuscul Dis 2007; 8: 187–94.
34. Johnson GL, Collier KE, Edwards DJ et al. Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis. J Clin Neuromuscul Dis 2009; 10: 178–84.
35. Gualano B, Neves M Jr, Lima FR et al. Resistance training with vascular occlusion in inclusion body myositis: a case study. Med Sci Sports Exerc 2010; 42: 250–4.
36. Omori C, Prado DM, Gualano B et al. Responsiveness to exercise training in juvenile dermatomyositis: a twin study. BMC Musculoskelet Disord 2010; 11: 270.
37. Omori CH, Silva CAA, Sallum AME et al. Exercise training in juvenile dermatomyosits. Arthritis Care Res (Hoboken) 2012; 64: 1186–94.
38. Riisager M, Mathiesen PR, Vissing J et al. Aerobic training in persons who have recovered from juvenile dermatomyositis. Neuromuscul Disord 2013; 23: 962–8.
39. Takken T, Spermon N, Helders PJ et al. Aerobic capacity in patients with juvenile dermatomyositis. J Rheumatol 2003; 39: 1075–80.
40. Takken T, van der Net J, Helders PJ. Anaerobic exercise capacity in patients with juvenile-onset of idiopathic inflammatory myopathies. Arthritis Rheum 2005; 53: 304–7.
41. Maillard SM, Jones R, Owens CM et al. Quantitative assessment of the effects of a single exercise session on muscles in juvenile dermatomyositis. Arthritis Rheum 2005; 53: 558–64.
42. Habers GE, De Knikker R, Van Brussel M et al. Near-infrared spectroscopy during exercise and recovery in children with juvenile dermatomyositis. Muscle Nerve 2013; 47: 108–15.
43. Miller FW, Rider LG, Chung YL et al. Proposed preliminary core set measures for disease outcome measures in adult and juvenile inflammatory myopathies. Rheumatology (Oxford) 2001; 40: 1262–73.
44. Rider LG, Giannini EH, Brunner HI et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004; 50: 2280–90.
45. Rider LG, Giannini EH, Harris-Love M et al. Defining clinical improvement in adult and juvenile myositis. J Rheumatol 2003; 30: 603–17.
46. Verhoven AC, Boers M, van der Liden S. Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. J Rheumatol 2000; 27: 2801–9.
47. Alemo Munters L, van Vollenhoven RF, Alexanderson H. Patient preference assessment reveals disease aspects not covered by recommended outcomes in polymyositis and dermatomyositis. ISRN Rheumatol 2011; doi: 5402/2011/463124.
48. Alexanderson H, Lundberg IE, Stenström CH. Development of the myositis activities profile – validity and reliability of a self-administrated questionnaire to assess activity limitation in patients with polymyositis/dermatomyositis. J Rheumatol 2002; 29: 2386–92.
49. Fries JF, Spitz P, Kraines RG et al. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–45.
50. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey: conceptual framework and item selection. Med Care 1992; 30: 473–83.
51. Varni JW, Seid M, Smith Knight T et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory generic core scales and rheumatology modules. Arthritis Rheum 2002; 46: 714–25.
52. Benatti FB, Pederson BK. Exercise as an anti-inflammatory therapy for rheumatic diseases – myokine regulation. Nat Rev Rheumatol 2014; 11: 86–97.
53. Weiss LW, Coney HD, Clarke FC. Differentional functional adaptations to short-term low-, moderate-, and high repetition weight training. J Strength Cond Res 1999; 13: 236–41.
54. Wiesinger GF, Quittan M, Nuhr M et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 2000; 81: 1–5.
55. Takarada Y, Takazawa H, Sato Y et al. Effects of resistance exercise combined with moderate vascular occlusion on muscular function in humans. J Appl Physiol 2000; 88: 2097–106.
56. Ewing Garber C, Blissmer B, Deschenes MR et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011; 43: 1334–59.